trial → CapableOf → evaluate efficacy
Typicality: 0.667
Saliency: 0.711
Facets 3
in subjects 19 location
in patients with gastroesophageal reflux disease 10 other
in combination with sorafenib 8 other
Open triples 9
trial → evaluate → efficacy 117
trial → assess → efficacy 59
trial → examine → efficacy 25
trial → investigate → efficacy 16
trial → determine → efficacy 15
trial → evaluate → the efficacy 6
trial → look at → efficacy 6
trial → measure → efficacy 5
trial → assess → the efficacy 3
Sentiment analysis
negative neutral positive
0.056 0.806 0.137
Other statistics
Raw frequency 252
Normalized frequency 0.711
Modifier score 0.850
Perplexity 201.475